FDA slaps Emcure with import alert, adding to ban on Indian plants

The FDA has banned yet another Indian drug plant. An import alert for all human and animal drugs from an Emcure Pharmaceuticals plant in Hinjawadi, with a few exceptions, was issued on Monday, according to the FDA. More from FiercePharmaManufacturing

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.